EXACT Sciences Corp (EXAS)
$2.71
0.01 (+0.37%)
| CAPS Rating |
|
|---|---|
| Open | $2.65 |
| Previous Close | $2.70 |
| Daily Range | $2.65 - $2.74 |
| 52-Week Range | $0.33 - $3.15 |
| Market Cap | $96.47M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 4,397 |
| Average Daily Volume | 43,000 |
EXAS
VS S&P 500 (SPY)
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
EXAS Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
EXAS News and Commentary
- 5 Stocks Approaching Greatness – The Motley Fool
- Bridge to Freedom – Blog at The Motley Fool
- Looking at my smallcaps: 3 potential 10 baggers. – Blog at The Motley Fool
- Letter from my investment advisor: – Blog at The Motley Fool
- Unloved Stocks Ready to Shine – The Motley Fool
- Do These Stocks Deserve Your Support? – The Motley Fool
- A New Emerging Diagnostics Index – Blog at The Motley Fool
- 10 Stocks Under Attack – The Motley Fool
- ColoSure and Cost Reductions Are Key to the Future of EXACT Sciences – Blog at The Motley Fool
- Today's 5-Star Movers – The Motley Fool
- Today's 5-Star Movers – The Motley Fool
- Today's 5-Star Movers – The Motley Fool
- Nibbling – Blog at The Motley Fool
- Closing EXAS (Exact Sciences) underperform – Blog at The Motley Fool
- Heads Up, Biotech Investors – The Motley Fool
- Detecting an Opportunity in EXACT Sciences – The Motley Fool
Related News and Articles
- Dream Stocks for Biotech Investors – The Motley Fool
- Still Enjoying Those Acquisitions, Pfizer? – The Motley Fool
RSS Headlines
Fool UK
